Acer Therapeutics Inc

NASDAQ:ACER   3:59:40 PM EDT
2.62
-0.03 (-1.13%)
Other Pre-Announcement

Acer Therapeutics Reports Q3 2020 Financial Results

Published: 11/10/2020 21:29 GMT
Acer Therapeutics Inc (ACER) - Acer Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.51.
Q3 Earnings per Share Estimate $-0.46 -- Refinitiv Ibes Data (analyst estimates).
Cash and Cash Equivalents Were $6.2 Million As of September 30, 2020.
Acer Therapeutics - Will Be Able to Fund Its Current Operations Into Q1 of 2021.